NKGen Biotech, Inc.
NKGN
$0.06
$0.000.00%
OTC PK
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 6.00K | 106.00K | 8.00K | 79.00K | 34.00K |
| Total Receivables | 23.00K | 24.00K | 24.00K | 23.00K | 26.00K |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 648.00K | 519.00K | 650.00K | 873.00K | 1.25M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 1.70M | 1.81M | 229.00K | 274.00K | 297.00K |
| Total Current Assets | 2.38M | 2.46M | 911.00K | 1.25M | 1.61M |
|
|
|||||
| Total Current Assets | 2.38M | 2.46M | 911.00K | 1.25M | 1.61M |
| Net Property, Plant & Equipment | 13.37M | 13.68M | 13.99M | 14.31M | 14.62M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | 96.00K | 96.00K | 93.00K | 93.00K | 91.00K |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 15.84M | 16.23M | 15.00M | 15.65M | 16.32M |
|
|
|||||
| Total Accounts Payable | 15.24M | 14.39M | 13.45M | 12.69M | 12.84M |
| Total Accrued Expenses | 1.29M | 1.10M | 2.32M | 2.30M | 2.36M |
| Short-term Debt | 26.76M | 41.67M | 19.70M | 17.25M | 11.57M |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 154.00K | 154.00K | 154.00K | 154.00K | 154.00K |
| Total Finance Division Other Current Liabilities | 448.00K | 659.00K | 1.49M | 19.01M | 10.57M |
| Total Other Current Liabilities | 448.00K | 659.00K | 1.49M | 19.01M | 10.57M |
| Total Current Liabilities | 43.89M | 57.97M | 37.12M | 51.41M | 37.48M |
|
|
|||||
| Total Current Liabilities | 43.89M | 57.97M | 37.12M | 51.41M | 37.48M |
| Long-Term Debt | 11.08M | 10.84M | 10.60M | 10.37M | 10.15M |
| Short-term Debt | 26.76M | 41.67M | 19.70M | 17.25M | 11.57M |
| Capital Leases | 206.00K | 246.00K | 282.00K | 316.00K | 348.00K |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 11.00M | 17.08M | 14.04M | 23.27M | 23.39M |
| Total Liabilities | 66.17M | 86.14M | 62.05M | 85.37M | 71.37M |
|
|
|||||
| Common Stock & APIC | 140.92M | 136.69M | 130.20M | 124.59M | 122.85M |
| Retained Earnings | -191.07M | -206.42M | -177.00M | -183.60M | -167.51M |
| Treasury Stock & Other | -182.00K | -182.00K | -251.00K | -10.71M | -10.39M |
| Total Common Equity | -50.33M | -69.91M | -47.05M | -69.72M | -55.06M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -50.33M | -69.91M | -47.05M | -69.72M | -55.06M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -50.33M | -69.91M | -47.05M | -69.72M | -55.06M |
|
|
|||||